Younger adults with lung cancer more likely to have targetable genetic changes

Health technology can be useful, but it becomes risky when people mistake consumer sensors for medical devices. The key is understanding what the data actually shows and what it doesn’t.

Reporting

Medical Xpress reports that Younger adults with lung cancer more likely to have targetable genetic changes, study finds. Younger adults with non-small cell lung cancer are significantly more likely than older patients to have genetic alterations that can be matched with targeted therapies, according to a large international study led in part by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. The key issue is evidence: what the device measures, how reliable the measurement is, who can safely use it, and where medical guidance is still needed.

The Details

• Medical Xpress: Younger adults with lung cancer more likely to have targetable genetic changes, study finds
• Younger adults with non-small cell lung cancer are significantly more likely than older patients to have genetic alterations that can be matched with targeted therapies, according to a

Next Developments

• peer review and replication of findings
• clinical applications and guidelines
• consult healthcare providers for personal advice

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.